SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-005622
Filing Date
2021-05-13
Accepted
2021-05-13 16:43:14
Documents
5
Period of Report
2021-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT a8kpressreleaseearnings.htm 8-K 34122
2 ADDITIONAL EXHIBITS q12021earningsrelease0512.htm EX-99 27543
3 IMAGE mnprlogo3.jpg GRAPHIC 8183
4 IMAGE q12021earningsrelease0512001.jpg GRAPHIC 933
5 IMAGE q12021earningsrelease0512002.jpg GRAPHIC 913
  Complete submission text file 0001654954-21-005622.txt   77061
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 21920297
SIC: 2834 Pharmaceutical Preparations